Src as a novel therapeutic target for endometriosis

Area of Science:

• Reproductive biology
• Oncology
• Cell biology

Background:

• Endometriosis is a common condition linked to increased ovarian cancer risk.
• Current in vitro models are insufficient for studying neoplastic transformation in endometriosis.
• Novel models are needed for understanding disease progression and developing treatments.

Purpose of the Study:

• To generate and characterize novel TERT-immortalized ovarian endometriosis epithelial cell lines (EEC16-TERT).
• To establish a more accurate in vitro model for endometriosis-associated ovarian cancer research.
• To identify potential therapeutic targets for preventing cancer development from endometriosis.

Main Methods:

• TERT gene was used to immortalize human endometriosis epithelial cells.
• Generated cell lines (EEC16-TERT) were characterized in vitro.
• Cells were assessed for tumorigenicity, anchorage-independent growth, and pathway activation.

Main Results:

• TERT expression successfully immortalized endometriosis epithelial cells.
• TERT immortalization induced epithelial-to-mesenchymal transition and altered cancer-related gene expression.
• The EEC16-TERT model showed Src pathway activation, a key factor in endometriosis-associated ovarian cancer.

Conclusions:

• The novel EEC16-TERT cell line serves as a valuable in vitro model for endometriosis and early neoplastic transformation.
• Src pathway activation is identified as a potential therapeutic target in endometriosis.
• Targeting the Src pathway may offer a novel strategy for managing endometriosis and preventing ovarian cancer.